Company intelligence / Profile preview

Kangyuan Biomedical

Wuhan, Hubei, Chinaen.kangyuan.com.cn ↗
Ownership
Private
Employees
~101
Development stage
Commercial
01

Overview

Wuhan Huaxin Kangyuan Biomedical is an active Chinese biotech company focused on developing biologic drugs for autoimmune diseases, with its lead candidate UBP-1213 targeting BAFF currently in Phase 1/2 clinical trials for systemic lupus erythematosus. Other companies under the "Kangyuan" name are involved in pharmaceutical manufacturing—especially hormones and herbal extracts—and medical device materials such as blood purification adsorbents and nano-antibodies. The group has R&D collaborations with academic institutions and operates GMP-certified facilities across China.[1][3][4][5][6]

Therapeutic areas
OtherImmunology
Modalities
Small molecule (e.g. herbal extracts)Biologic (e.g. recombinant proteins like urokinase)Antibody (nano-antibody-based diagnostics and therapeutics)
Industry
Biotech
02

Partnerships

Shaanxi University of Chinese MedicineChinese Academy of Sciences involvement via joint ventureShanghai Junshi Biosciences

Beyond the preview

Go deeper on Kangyuan Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangyuan Biomedical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call